人类干细胞特定的表观遗传特征控制了转基因表达
Chulhwan S Kwak1, Furkan E Oflaz1, Jiamin Qiu1
1Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
Biochimica et biophysica acta. Gene regulatory mechanisms
|October 22, 2024
概括
表观遗传沉默阻碍了人类干细胞中的基因表达. 研究人员发现,EF1α短促销器和miniUCOE元素可以克服这种沉默,改善诱导多能干细胞中的转基因表达.
科学领域:
- 分子生物学分子生物学
- 干细胞研究的研究.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 人类干细胞模型对于研究分化和疾病至关重要.
- 干细胞中的表观遗传沉默限制了遗传工具的使用.
- 了解基因沉默机制对于干细胞应用至关重要.
研究的目的:
- 研究人类干细胞中外源基因沉默的分子机制.
- 确定能够在诱导多能干细胞 (iPSC) 中克服表观遗传沉默的促进体.
- 开发增强iPSC转基因表达的策略.
主要方法:
- 在人类诱导多能干细胞 (iPSCs),质母细胞细胞 (GBM) 和胚胎细胞 (HEK) 中利用了多种常用的促进剂.
- 分析了CpG甲基化模式和蛋白质表达水平.
- 测试了延长因子1α短 (EF1α短或EFS) 促进剂和最小A2无处不在的染色体开放元件 (miniUCOE) 的有效性.
主要成果:
- 与非iPSC相比,所有测试的促进剂在iPSC中显示出高CpG甲基化和较低的蛋白质表达.
- 尽管CpG甲基化,但EF1α短促剂在iPSC中表现出相对较高的基因表达.
- 在促进体上游加入一个miniUCOE元素抑制了CpG甲基化,并促进了iPSCs中的基因表达.
结论:
- 干细胞类型特定的表观遗传修饰会影响转基因促进体区域.
- EF1α短促剂和miniUCOE提供了增强iPSC转基因表达的有希望的策略.
- 这些发现为在干细胞研究中设计抗沉默策略提供了宝贵的见解.
相关概念视频
02:33Combinatorial Gene Control
8.3K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
8.3K
01:24Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
01:29Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
01:32Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
01:58Cell Specific Gene Expression
4.6K
4.6K